4.2 Article

Probiotics: Which and when?

期刊

DIGESTIVE DISEASES
卷 26, 期 2, 页码 175-182

出版社

KARGER
DOI: 10.1159/000116776

关键词

microbiota; probiotics; functional foods; gut; intestine functions

向作者/读者索取更多资源

There is a natural feeling between our intestinal flora and the gut. These microorganisms, living in the various tracts of human intestine, may affect the host homeostasis. Some of these bacteria can perhaps be a source of infection and sepsis when the bowel barrier is physically or functionally breached. The term 'probiotic' dates from the beginning of the last century and in the last years a market for probiotics worldwide, estimated to be worth billions of pounds, has developed. Although there is persuasive advertising for probiotics and there have been methodological advances in the study of the intestinal microbiota, much remains unproven, e. g. how probiotics work, which strains are effective, what can be expected to be achieved, and what dosage is required for effectiveness. This review of the literature is an evidence-based guide through the developing microbial universe affecting our life. Copyright (c) 2008 S. Karger AG, Basel.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

Post-COVID-19 Gastro-Intestinal Disturbances

Emidio Scarpellini, Jan Tack

Summary: Background: Since the end of 2019, SARS-CoV-2 has caused the COVID-19 pandemic, and gastrointestinal (GI) symptoms during and after COVID-19 are receiving increasing attention. Methods: We review and comment on the prevalence, pathophysiology, and potential treatment options for GI disturbances in COVID-19. Results: Numerous reports show that a significant portion of COVID-19 patients experience GI symptoms both during and after the disease, with some experiencing symptoms for several months, even after vaccination. There is an ongoing debate regarding the association between GI symptoms and the outcome of COVID-19 patients. However, it is widely recognized that patients with chronic liver disease have a worse outcome. The similarities between GI symptoms and postinfectious functional dyspepsia and irritable bowel syndrome suggest that the gut microbiota may play a role. Preliminary reports and clinical trials have shown that modulating the gut microbiota could be an effective approach for treating and preventing COVID-19. Conclusion: GI symptoms have a significant impact on the natural course of both long-COVID-19 and non-long-COVID-19. Modulating the gut microbiota appears to be a promising target for disease treatment and prevention.

REVIEWS ON RECENT CLINICAL TRIALS (2023)

Correction Medicine, General & Internal

Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization (vol 17, pg 917, 2022)

Maurizio Gabrielli, Giulia Pignataro, Marcello Candelli, Marta Sacco Fernandez, Martina Bizzarri, Alessandra Esperide, Francesco Franceschi

INTERNAL AND EMERGENCY MEDICINE (2023)

Article Nutrition & Dietetics

Effect of Immuno-Nutrition on Malnutrition, Inflammatory Response and Clinical Course of Semi-Critically Ill COVID-19 Patients: A Pilot Perspective Study

Marialaura Scarcella, Emidio Scarpellini, Sara Piergallini, Emanuele Rinninella, Karen Routhiaux, Carlo Rasetti, Ludovico Abenavoli, Edoardo De Robertis, Pietro Manzi, Rita Commissari, Riccardo Monti, Michela Zanetti

Summary: In this study, we found that immune-nutrition (IN) can prevent malnutrition and decrease inflammatory markers in overweight patients with COVID-19 during the fourth wave of the pandemic in 2021.

NUTRIENTS (2023)

Review Genetics & Heredity

Human Genes Involved in the Interaction between Host and Gut Microbiome: Regulation and Pathogenic Mechanisms

Luigi Boccuto, Jan Tack, Gianluca Ianiro, Ludovico Abenavoli, Emidio Scarpellini

Summary: The human gut microbiota is a complex ecosystem that includes bacteria, viruses, protozoa, archaea, fungi, and yeasts. The gut microbiome refers to the genome of these microbes actively involved in functions such as digestion, immune system regulation, and metabolism. The interaction between the gut microbiome and human genes plays a crucial role in human health and disease.
Review Nutrition & Dietetics

Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition

Ludovico Abenavoli, Emidio Scarpellini, Maria Rosaria Paravati, Giuseppe Guido Maria Scarlata, Luigi Boccuto, Bruno Tilocca, Paola Roncada, Francesco Luzza

Summary: Critically ill patients often experience a hyper-inflammatory response, which can cause severe damage to tissues and organs. It has been found that this harmful inflammatory cascade can be traced back to imbalances in the gut microbiota. Understanding the dysfunction and pathophysiology of the gut microbiota in critical patients is crucial for managing the systemic inflammatory response syndrome and multiple organ dysfunction syndrome. Various studies have shown that probiotics and immunonutrition can help attenuate systemic inflammation in critically ill patients.

NUTRIENTS (2023)

Article Biochemistry & Molecular Biology

Impact of Immuno-Nutrition on the Nutritional Status, Inflammatory Response and Clinical Outcome of Clinic-Admitted Mild-Intensity-COVID-19 Patients: A Pilot, Perspective-Concluding Study

Martina Basilico, Marialaura Scarcella, Emanuele Rinninella, Nena Giostra, Stefano Marcelli, Carlo Rasetti, Jan Tack, Ludovico Abenavoli, Emidio Scarpellini

Summary: This study evaluated the impact of a standardized oral immuno-nutrition formula on COVID-19 patients. The findings showed that immuno-nutrition therapy can lower the levels of inflammatory markers, prevent the deterioration of BMI and phase angle, and prevent the development of malnutrition in overweight COVID-19 patients.

METABOLITES (2023)

Review Biochemistry & Molecular Biology

Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection

Ludovico Abenavoli, Giuseppe Guido Maria Scarlata, Maria Rosaria Paravati, Luigi Boccuto, Francesco Luzza, Emidio Scarpellini

Summary: Liver transplantation is the preferred treatment for patients with certain liver conditions, but rejection after transplantation is a significant issue. The gut microbiota is involved in the gut-liver axis and can affect the immune response, potentially leading to graft rejection. Evaluating changes in the gut microbiota composition is essential for monitoring the success of liver transplantation and implementing appropriate preventive measures.

BIOMEDICINES (2023)

Review Medicine, General & Internal

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome

Ludovico Abenavoli, Giuseppe Guido Maria Scarlata, Emidio Scarpellini, Luigi Boccuto, Rocco Spagnuolo, Bruno Tilocca, Paola Roncada, Francesco Luzza

Summary: Metabolic-dysfunction-associated fatty liver disease (MAFLD) is a newly named condition that links non-alcoholic fatty liver disease (NAFLD) with metabolic dysfunction. Its diagnosis is still debated and is generally associated with steatosis and at least one pathological condition among overweight/obesity, type 2 diabetes mellitus, and metabolic dysregulation. The pathogenesis of MAFLD involves changes in the gut microbiota, which has also been investigated in other diseases such as obesity, type 2 diabetes mellitus, and NAFLD. However, only a few studies have specifically correlated gut dysbiosis with MAFLD.

MEDICINA-LITHUANIA (2023)

Review Medicine, Research & Experimental

Decompressive Craniectomy in Severe Traumatic Brain Injury: The Intensivist's Point of View

Matteo Vitali, Stefano Marasco, Tatsiana Romenskaya, Angela Elia, Yaroslava Longhitano, Christian Zanza, Ludovico Abenavoli, Emidio Scarpellini, Alessandro Bertuccio, Andrea Barbanera

Summary: Traumatic brain injury is a severe pathology with significant social and economic concerns. Decompressive craniectomy is a life-saving surgical option for treating elevated intracranial hypertension. This narrative review summarizes the literature and discusses key issues related to indication, timing, surgical procedure, outcome, and complications in adult patients undergoing decompressive craniectomy for severe traumatic brain injury.

DISEASES (2023)

Article Emergency Medicine

A new simple score to predict mortality of COVID-19 in the emergency department

Marcello Candelli, Giulia Pignataro, Marta Sacco Fernandez, Sara Cicchinelli, Antonio Gulli, Enrico Torelli, Maurizio Gabrielli, Andrea Piccioni, Marcello Covino, Veronica Ojetti, Massimo Antonelli, Antonio Gasbarrini, Francesco Franceschi

Summary: This study aims to evaluate clinical and laboratory indicators associated with mortality and determine a prognostic score based on these variables. A score called ANCOC (Age, blood urea Nitrogen, C-reactive protein, Oxygen saturation, Comorbidities) was created to predict the risk of death in COVID-19 patients. The ANCOC score showed high diagnostic accuracy in predicting mortality.

SIGNA VITAE (2023)

Article Medicine, General & Internal

Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study

Ludovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, Emidio Scarpellini, Luigi Boccuto, Francesco Luzza

Summary: This study investigated the prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with inflammatory bowel disease (IBD) using ultrasound examination. The results showed that the prevalence of NAFLD in IBD patients was 23%, with higher values of age, body mass index, waist circumference, disease duration, and age at onset observed in NAFLD patients. Additionally, NAFLD patients also exhibited a higher percentage of hypertension and metabolic comorbidities.

MEDICINA-LITHUANIA (2023)

暂无数据